Kathryn Foti1,2, Shakia T Hardy3, Alex R Chang4, Elizabeth Selvin1,2, Josef Coresh1,2, Paul Muntner3. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health. 2. Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland. 3. Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama. 4. Kidney Health Research Institute, Geisinger Health, Danville, Pennsylvania, USA.
Abstract
OBJECTIVES: Less than half of United States adults with hypertension have controlled blood pressure (BP). Higher BMI is associated with an increased risk for hypertension but the association between BMI and BP control is not well characterized. We examined hypertension awareness, antihypertensive medication use, and BP control, by BMI category. METHODS: Data for 3568 United States adults aged at least 18 years with hypertension (BP at least 140/90 mmHg or taking antihypertensive medication) from the 2015 to 2018 National Health and Nutrition Examination Survey were analyzed. BMI was categorized as normal (<25 kg/m2), overweight (25 to <30 kg/m2), class 1 obesity (30 to <35 kg/m2), or class 2 or 3 obesity (≥35 kg/m2). Hypertension awareness and antihypertensive medication use were self-reported. BP control was defined as BP less than 140/90 mmHg using the average of up to three measurements. RESULTS: Among United States adults with hypertension, 15.6% had normal BMI, 31.3% had overweight, 26.2% had class 1 obesity, and 26.8% had class 2 or 3 obesity. Among those with normal BMI, overweight, class 1 obesity, and class 2 or 3 obesity: 67.9, 76.8, 84.0, and 87.8% were aware they had hypertension, respectively; 88.1, 88.1, 90.9, and 90.2% of those aware were taking antihypertensive medication, respectively; 63.5, 65.9, 71.1, and 64.1% of those taking antihypertensive medication had controlled BP, respectively; and 37.1, 44.3, 53.8, and 50.8% of those with hypertension had controlled BP, respectively. CONCLUSION: United States adults with hypertension and normal BMI were less likely to be aware they had hypertension and have controlled BP compared with those with overweight or obesity.
OBJECTIVES: Less than half of United States adults with hypertension have controlled blood pressure (BP). Higher BMI is associated with an increased risk for hypertension but the association between BMI and BP control is not well characterized. We examined hypertension awareness, antihypertensive medication use, and BP control, by BMI category. METHODS: Data for 3568 United States adults aged at least 18 years with hypertension (BP at least 140/90 mmHg or taking antihypertensive medication) from the 2015 to 2018 National Health and Nutrition Examination Survey were analyzed. BMI was categorized as normal (<25 kg/m2), overweight (25 to <30 kg/m2), class 1 obesity (30 to <35 kg/m2), or class 2 or 3 obesity (≥35 kg/m2). Hypertension awareness and antihypertensive medication use were self-reported. BP control was defined as BP less than 140/90 mmHg using the average of up to three measurements. RESULTS: Among United States adults with hypertension, 15.6% had normal BMI, 31.3% had overweight, 26.2% had class 1 obesity, and 26.8% had class 2 or 3 obesity. Among those with normal BMI, overweight, class 1 obesity, and class 2 or 3 obesity: 67.9, 76.8, 84.0, and 87.8% were aware they had hypertension, respectively; 88.1, 88.1, 90.9, and 90.2% of those aware were taking antihypertensive medication, respectively; 63.5, 65.9, 71.1, and 64.1% of those taking antihypertensive medication had controlled BP, respectively; and 37.1, 44.3, 53.8, and 50.8% of those with hypertension had controlled BP, respectively. CONCLUSION: United States adults with hypertension and normal BMI were less likely to be aware they had hypertension and have controlled BP compared with those with overweight or obesity.
Authors: Jennifer D Parker; Makram Talih; Donald J Malec; Vladislav Beresovsky; Margaret Carroll; Joe F Gonzalez; Brady E Hamilton; Deborah D Ingram; Kenneth Kochanek; Frances McCarty; Chris Moriarity; Iris Shimizu; Alexander Strashny; Brian W Ward Journal: Vital Health Stat 2 Date: 2017-08
Authors: Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz Journal: JAMA Date: 2014-02-05 Impact factor: 56.272
Authors: Matthew T Crim; Sung Sug Sarah Yoon; Eduardo Ortiz; Hilary K Wall; Susan Schober; Cathleen Gillespie; Paul Sorlie; Nora Keenan; Darwin Labarthe; Yuling Hong Journal: Circ Cardiovasc Qual Outcomes Date: 2012-05-01
Authors: Michael E Hall; Jordana B Cohen; Jamy D Ard; Brent M Egan; John E Hall; Carl J Lavie; Jun Ma; Chiadi E Ndumele; Philip R Schauer; Daichi Shimbo Journal: Hypertension Date: 2021-09-20 Impact factor: 10.190
Authors: Vicente Gil-Guillén; Domingo Orozco-Beltrán; Rafael Peset Pérez; Jose Luis Alfonso; Josep Redón; Salvador Pertusa-Martínez; Jorge Navarro; Luis Cea-Calvo; Fernando Quirce-Andrés; Jaime Merino-Sánchez; Concepción Carratalá; José María Martín-Moreno Journal: Blood Press Date: 2010-02 Impact factor: 2.835
Authors: Sharon Saydah; Kai McKeever Bullard; Yiling Cheng; Mohammed K Ali; Edward W Gregg; Linda Geiss; Giuseppina Imperatore Journal: Obesity (Silver Spring) Date: 2014-04-15 Impact factor: 5.002